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Side chain to main chain hydrogen bonds stabilize
a polyglutamine helix in a transcription factor
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Polyglutamine (polyQ) tracts are regions of low sequence complexity frequently found in
transcription factors. Tract length often correlates with transcriptional activity and expan-
sion beyond specific thresholds in certain human proteins is the cause of polyQ disorders. To
study the structural basis of the association between tract length, transcriptional activity and
disease, we addressed how the conformation of the polyQ tract of the androgen receptor,
associated with spinobulbar muscular atrophy (SBMA), depends on its length. Here we
report that this sequence folds into a helical structure stabilized by unconventional hydrogen
bonds between glutamine side chains and main chain carbonyl groups, and that its helicity
directly correlates with tract length. These unusual hydrogen bonds are bifurcate with the
conventional hydrogen bonds stabilizing α-helices. Our findings suggest a plausible rationale
for the association between polyQ tract length and androgen receptor transcriptional activity
and have implications for establishing the mechanistic basis of SBMA.
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Polyglutamine (polyQ) tracts are low-complexity regions thatare composed almost exclusively of Gln residues. They arefrequent in the human proteome, particularly in the
intrinsically disordered domains of proteins involved in the reg-
ulation of transcription, such as the activation domains of tran-
scription factors1. The biological function of polyQ tracts is not
well understood, but it has been suggested that they regulate the
activity of the proteins that harbor them by modulating the sta-
bility of the complexes that they form2. The lengths of polyQ
tracts are variable because their coding DNA sequences tend to
adopt secondary structures that hamper replication and repair3.
Contractions and expansions in polyQ tracts can have functional
consequences, and the lengths of the tracts may have been subject
to natural selection4. As an example, it has been proposed that the
length of the polyQ tract present in the protein huntingtin cor-
relates with the intellectual coefficient5, presumably because it
plays important although still not well-defined roles in neural
plasticity6.
For nine specific proteins, the variability in the lengths of
polyQ tracts has pathogenic implications. Expansions beyond
protein-specific thresholds are associated with nine rare heredi-
tary neurodegenerative diseases known as polyQ diseases7. The
mechanistic basis of this phenomenon is a matter of debate. Some
authors have proposed that the expanded transcripts themselves
are the neurotoxic species8 due, possibly, to their propensity to
phase separate9, while others have suggested that expanded polyQ
proteins are inherently neurotoxic10. It is widely believed, how-
ever, that polyQ expansions cause neurotoxicity because they
decrease protein solubility, which in turn leads to the formation
of cytosolic or nuclear aggregates that interfere with proteasomal
protein degradation11 and sequester the transcriptional machin-
ery12. This notion is supported by experiments carried out
in vitro and in cells, which showed that polyQ expansion
decreases protein solubility13 and causes cell death14, as well as
in vivo, which revealed that enhanced polyQ aggregate clearance
leads to improvements in the phenotypes induced by the polyQ
expansion15.
It has been hypothesized that polyQ tracts have the generic
propensity to undergo a tract length-dependent conformational
change producing a highly insoluble structure when their lengths
reach the corresponding thresholds. A substantial number of
theoretical, computational, and experimental studies have thus
examined how the conformational properties of polyQ tracts
change with their length. Some of these studies have suggested
that expansions of the polyQ tract of huntingtin, associated with
Huntington disease16—the most common polyQ disease—confer
the ability to adopt extended conformations with β secondary
structure17. By contrast, most experimental studies carried out to
date report that polyQ tracts are collapsed disordered coils that
barely change conformation upon expansion18. These observa-
tions led to an alternative hypothesis that proposes that expan-
sion leads to toxicity by increasing the affinity of polyQ tracts for
their interactors, regardless of conformation19.
The androgen receptor (AR, 919 residues) is the nuclear
receptor that regulates the development of the male phenotype. It
harbors a polyQ tract whose helical propensity—that we have
recently revealed by nuclear magnetic resonance (NMR) and
circular dichroism (CD)20—increases upon expansion20,21. This
tract is associated with the neuromuscular disease spinobulbar
muscular atrophy (SBMA)22, a condition that affects men with
AR genetic variants coding for tracts with more than 37 residues,
which form fibrillar cytotoxic aggregates23. The length of this
tract also anti-correlates with the risk of suffering prostate can-
cer24 due to its influence on AR transcriptional activity25. It
therefore appears that the length of the polyQ tract of AR must be
in a specific range in order to prevent the over-activation of the
receptor in prostate cancer and simultaneously minimize its
propensity to form cytotoxic aggregates in SBMA. This trade-off
is reflected in the distribution of AR polyQ tract lengths in the
population, despite some variations between ethnic groups26.
Although these sequence–activity relationships are relevant for
understanding the causes of two diseases they have not been
rationalized, in part due to the difficulty in obtaining atomic
resolution structures of these poorly soluble repetitive sequences.
By establishing robust assays and analysis procedures, we have
generated conformational ensembles representing the structural
properties of the polyQ tract of the AR20 as a function of tract
length by reweighting trajectories obtained by molecular
dynamics (MD) on the basis of backbone chemical shifts mea-
sured by solution NMR spectroscopy, which we have validated by
using CD spectroscopy and QM/MM (quantum mechanics/
molecular mechanics) calculations. We find that the helicity of
the tract correlates with its length as a result of the accumulation
of unconventional interactions where Gln side chains donate a
hydrogen bond to the main chain carbonyl of the residue at
relative position i−4. In addition, we have found that the strength
of these interactions depends on the ability of the side chain of
the acceptor residue to shield the interacting moieties from
competition with water molecules, indicating that the secondary
structure of polyQ tracts can depend on their environment.
Taken together, our results suggest explanations for how changes
in polyQ tract length alter the transcriptional activity of AR and
its propensity to aggregate in SBMA, thus providing plausible
rationales for the range of tract lengths observed in men.
Results
The polyQ helix of AR gains stability upon expansion. To
confirm that the helical nature of the polyQ tract of AR20 stems
from local interactions and study how the N-terminal flanking
region influences helicity, we analyzed the secondary structure of
synthetic peptides uQ25, uL4Q25, and L4Q25 (Fig. 1a) at pH 7.4
and 277 K by CD. Peptide uQ25, where the letter u stands for
uncapped, represents a polyQ tract containing 25 residues flanked
by Lys residues, used to enhance solubility at physiological pH.
uL4Q25 has four Leu residues found N terminally to the polyQ
region in AR, while L4Q25 contains four additional AR residues
(Pro-Gly-Ala-Ser), predicted to act as N-capping motif27 (Sup-
plementary Fig. 1). As shown in Supplementary Fig. 2, the spectra
of uL4Q25 and in particular of L4Q25 have well-defined minima at
ca. 205–208 and 222 nm, thereby indicating that they are 40 and
55% helical, respectively. These results show that the helicity of
this polyQ tract stems from interactions involving eight residues
flanking it at the N terminus, including a predicted N-capping
motif and four Leu residues20.
To quantify the extent to which helicity is determined by tract
length, we used CD at pH 7.4 and 277 K to study polyQ peptides
equivalent to L4Q25, but with tract lengths of 4, 8, 12, 16, and 20
residues (L4Qn, Fig. 1a) and observed that they are strongly
correlated (Fig. 1b). Helicity increased abruptly from L4Q4 to
L4Q8 and L4Q12, from ca. 5% to ca. 40%, and then increased
slightly upon further expansion. Since the CD signal depends
both on the amount and length of helical structures, and to
determine the residue-specific distribution of helicity, we
measured the backbone chemical shifts of the peptides by
solution NMR at physiological pH and 278 K (Supplementary
Figs. 3 and 4) and analyzed them with the algorithm δ2D28. In
agreement with the results obtained by CD, helical propensity
increased upon polyQ tract expansion (Fig. 1c), concomitant with
a change in the identity of the residue with the highest helicity:
whereas for L4Q4 this is L3, it shifts to L4 for L4Q8 and L4Q12 and
to Q1 for L4Q16 and L4Q20 (Fig. 1c). Although it is likely that the
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large differences in helicity that we observe will be attenuated at
physiological temperature, we conclude that the helical propen-
sity of this polyQ tract depends on its length and that the residue
with the highest helicity can be part of the tract.
The Gln side chains have a well-defined conformation. To
rationalize the stability of the polyQ helix, we extended our NMR
analysis to the side chains and initially focused on the carbox-
amide groups of the Gln residues (Supplementary Fig. 5). We
found that the 15N side chain resonances of the homopolymeric
polyQ sequences are well dispersed and that the associated che-
mical shifts correlate with their position in the sequence, that is,
that the resonances of the first residue of the tract appear up-field
(111.75 ppm for Q1 in L4Q20) (Fig. 2a) and shift to lower fields
towards its C terminus (113.15 ppm for Q20 in L4Q20).
Remarkably, the first four residues (Q1–Q4) have chemical shifts
that are markedly lower; for example, in L4Q20 the difference in
side chain 15N chemical shift between Q4 and Q5 is 0.22 ppm,
whereas the resonances of Q5 and Q6 overlap. These observations
indicate that the chemical environment of the Gln side chains
varies along the polyQ tract, especially for the first residues.
We then analyzed the 1H resonances of the Gln side chains.
Particularly in the first residues of the tract, the resonances of the
γ protons, adjacent to the carboxamide group (Fig. 2b), overlap in
the peptide with the shortest tract, but gradually split as the
length of the tract increases to 20. The behavior of the β protons,
which are instead adjacent to the peptide backbone (Fig. 2c and
Supplementary Fig. 6), is more complex. In L4Q4 they are split,
and upon tract expansion to L4Q12, they collapse into one peak,
but then split again in L4Q16 and especially in L4Q20. These
effects, caused by redistributions of side chain rotameric states,
correlate with the increases in helicity that occur upon tract
expansion reported in Fig. 1c and indicate that the conformations
of the main chain and side chain of these residues are not
independent. Although these effects are particularly marked for
the first three or four residues of the tract, they can also be seen in
the residues following them in the sequence, particularly in L4Q16
and L4Q20 (Supplementary Fig. 6). This indicates that, in a given
peptide, the population of the side chain conformation causing
the effects gradually decreases along the sequence. In summary,
we found that the conformational properties of the side chains of
Gln residues correlate with their helicity.
Hydrogen bonds between Gln side chains and the main chain.
To rationalize these observations, we produced conformational
ensembles for each peptide by using the NMR backbone chemical
shifts to reweight all atom MD trajectories. First, given that all
peptides have fractional helicity, we sampled the conformational
space available to them by generating fully helical conformations
and simulating their dynamics for up to 5 μs at 300 K in explicit
solvent. We observed that the helical starting structures had a
lifetime that depended on the size of the system and that partially
helical conformations were re-populated after unfolding even for
the largest one, L4Q20 (Supplementary Fig. 7). These findings
indicate that both the helical and unfolded states of the peptides
were sampled under these conditions, which is necessary for
reweighting procedures to perform well29. Then, we used the Cα
and CO backbone chemical shifts to reweight the trajectories with
a Bayesian/maximum entropy (BME) algorithm30. In this pro-
cedure, the degree of reweighting and, therefore, the extent to
which the back-calculated chemical shifts agree with those mea-
sured experimentally is controlled by the parameter θ, which
determines the balance between the prior information encoded in
the MD trajectory and the experimental data (Supplementary
Figs. 8 and 9 and, for θ= 4, Fig. 3b). We analyzed the secondary
structure of the reweighted trajectories and found that their
overall helicity increased with the length of the polyQ tract
(Fig. 3a), as observed by CD (Fig. 1b). Furthermore, after
reweighting the effect of expansion on the helicity of the various
residues of the peptide was found to be equivalent to that
observed by NMR, thereby indicating that the procedure yielded
structural ensembles that are useful models of the conformational
properties of polyQ peptides under the conditions used for the
CD and NMR experiments (Fig. 3c).
The 15N chemical shifts of backbone amides depend on the
hydrogen bonding status of both the HN group and the adjacent
CO31. We thus hypothesized that the high dispersion of 15N Gln
side chain resonances (Fig. 2a) is due to hydrogen bonding
interactions of the carboxamide group of the Gln side chains. The
primary amide (NH2) groups of Gln and Asn side chains are good
donors32, and in folded proteins Gln residues have been found to
donate hydrogens to the backbone COs preceding them in the
sequence33. To study this possibility, we analyzed the hydrogen
bonds formed by Gln side chains in the reweighted trajectories.
We found that in the most frequent hydrogen bond the side chain
of a Gln residue donates a hydrogen to the main chain CO group
of the residue at relative position i− 4 in the sequence (Fig. 4a).
This specific interaction, which we call i→ i− 4 side chain to
main chain hydrogen bond—that is, sc(i)→mc(i− 4), has been
reported in protein structures deposited in the protein data bank
(PDB). Interestingly, it occurs almost exclusively in α-helices both
in the PDB33 and in the trajectories (Supplementary Fig. 10), thus
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suggesting that it plays a role in stabilizing this secondary struc-
ture. In addition, for the reweighted MD ensembles of all the
peptides, we observed that the frequency of this specific hydrogen
bond decreases along the polyQ tract (Fig. 4b).
We analyzed the rotameric distributions of Gln residues
involved in these hydrogen bonds in the reweighted trajectories
and observed that they constrain the range of values of χ1 and χ3
that they can adopt (Fig. 4c). Note that while the distribution of
χ1 in Gln residues in α-helices is generally bimodal34, only χ1
values around −60° are compatible with the suggested H-bonding
network, which also results in an enrichment of χ3 values around
90°. Remarkably, these observations agree with the NMR results,
which point to the adoption of a specific conformation state by
these side chains (Fig. 2c). Since the main chain chemical shifts
used to reweight the MD trajectories do not directly report on
side chain conformation, this result suggests that the main chain
and side chain conformations are not independent, a property
that is to some extent encoded in the MD force field. As an
example, we show a frame of the trajectory obtained for peptide
L4Q16 in which two such hydrogen bonds occur simultaneously
(involving residues Q1 and Q4 but not Q2 and Q3; Fig. 4d). The
NMR-derived structural ensembles thus suggest that sc(i)→mc
(i− 4) hydrogen bonds can be part of a hydrogen bonding
network in which the CO group accepts two hydrogen bonds
donated by the Gln side (purple) and main (yellow) chains.
Sc(i)→mc(i− 4) hydrogen bonds stabilize the polyQ helix. To
test the importance of sc(i)→mc(i− 4) hydrogen bonds, we used
CD to analyze the secondary structure of a series of peptides
based on the L4Q16 sequence with Gln residues mutated to Glu
(Fig. 5a, b). Gln and Glu have similar structures and helical
propensities35, but the side chain of the latter is deprotonated at
pH 7.4 and cannot act as a hydrogen bond donor. Decreases in
helicity after mutation of Gln residues are thus compatible with
the involvement of these residues in helix stabilization via sc(i)→
mc(i− 4) hydrogen bonds. Since the frequency of such hydrogen
bonds in the NMR-derived ensembles was highest at the N ter-
minus of the tract (Fig. 4b), we analyzed the effect of mutating,
one at a time, the first five Gln residues (peptides Q1E to Q5E).
We found that the helicity of peptides Q1E to Q4E was lower
than that of L4Q16. We observed a shift of the minimum at ca.
205–208 nm to lower wavelengths and a relative decrease in the
ellipticity at 222 nm, which, together, accounted for a decrease in
helicity from 40 to 30%. By contrast, we found that the helicity of
Q5E was very similar to that of L4Q16 (Fig. 5c and Supplementary
Fig. 11), thereby suggesting that the propensity of the first four
Gln residues to donate a hydrogen is higher than that of the fifth
one. This finding is in agreement with the 15N Gln side chain
chemical shifts, where we observed especially low values for the
first four residues, which could be attributed to particularly strong
hydrogen bonding interactions (Fig. 2a). We also analyzed a
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mutant where the first four hydrogen-bonded Gln residues were
simultaneously mutated to Glu (Q1-4E) and found that in this
case the loss of helicity was larger, from 40 to 20%, similar to the
value found in uQ25 (Fig. 5b, c and Supplementary Fig. 11).
Since the pKa of Glu side chains is ca. 4, decreasing the pH of
solutions of peptide Q1-4E to 2 should lead to their protonation
and re-establish their ability to form sc(i)→mc(i− 4) hydrogen
bonds. To test this hypothesis, we analyzed the secondary
structure of peptides L4Q16 and Q1-4E at pH 2 and 277 K by CD.
As expected, we observed no change in the secondary structure of
L4Q16. In contrast, for Q1-4E, we observed that this peptide was
strongly helical at low pH, more so than L4Q16 (Supplementary
Fig. 12). This observation suggested that, when protonated, Glu
side chains, due to their acidic character, have an even higher
propensity than Gln residues to donate a hydrogen bond to the
main chain CO of the residue at position i− 4. These results
validate our approach to investigate side chain to main hydrogen
bonds by Gln to Glu mutations and, in addition, contribute to
explaining the high helical propensity observed in host–guest
experiments for protonated Glu residues, where they were found
to be more helical than any other amino acid except Ala35.
It is remarkable that the first side chains of the polyQ tract
have a particularly high propensity to form sc(i)→mc(i− 4)
hydrogen bonds. The other Gln residues also form these bonds
but to a lower extent as indicated, for example, by their side chain
chemical shifts. One difference between these two sets of Gln
residues is that the former are at position i+ 4 relative to Leu
residues, whereas the latter are at position i+ 4 relative to other
Gln residues (Fig. 5b). Since the strength of hydrogen bonds
depends on their degree of shielding from water36, we
hypothesized that the sc(i)→mc(i− 4) hydrogen bonds between
Gln and Leu residues are stronger, at least in part, due to
shielding of water by Leu side chains. Indeed, as α-helices have
3.6 residues per turn, the sc(i)→mc(i− 4) hydrogen bond
between residues L1 and Q1 can be shielded by the side chain of
residue i (L1) (Fig. 5b). To study this point, we measured the
helicity of a peptide based on the sequence of L4Q16 but with all
Leu residues mutated to Ala (L1-4A), an amino acid that has a
smaller side chain and, presumably, a lower ability to shield this
hydrogen bond. Despite the higher intrinsic helical propensity of
Ala compared to Leu35 and the higher predicted helicity of L1-4A
compared to L4Q16 (Supplementary Fig. 13), we found that
substitution of the four Leu for Ala residues reduced the helical
content from 40% in peptide L4Q16 to ca. 20% in L1-4E, a value as
low as that of Q1-4E (Supplementary Fig. 14 and Fig. 5c). This
finding confirms that the shielding properties of the Leu side
chains are indeed key for the strength of this interaction and for
its ability to stabilize polyQ helices. In addition, it indicates that
accounting for the sc(i)→mc(i− 4) hydrogen bond revealed in
this work will be important to reliably predict the helicity of
polyQ peptides on the basis of their sequences (Supplementary
Fig. 13).
To confirm that the shielding provided by Leu is relevant for
the ability of Gln to donate a hydrogen bond to the residue at
relative position i− 4, we characterized the synthetic peptide L1-
4A by NMR. We compared the side chain 1H,15N resonances of
peptide L1-4A with those of L4Q16 by carrying out 1H,15N-HSQC
experiments at natural 15N abundance. We observed that there
was a remarkable loss of dispersion in the 15N chemical shift
dimension for L1-4A: except for the last three Gln residues, all
other residues in the tract have the same 15N chemical shift
(Fig. 5d). We then analyzed the aliphatic 1H resonances of the
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Gln side chains and observed that, in contrast to L4Q16, the
signals of Q1 to Q4 in L1-4A display collapsed γ and split β
resonances, thus indicating that these side chains do not have the
same conformation as in L4Q16.
Backbone carbonyls form bifurcated hydrogen bonds. Our
results suggest that the side and main chains of Gln can simul-
taneously donate a hydrogen to the CO of the residue at relative
position i− 4 (Fig. 4d). This process can generate a type of
bifurcate hydrogen bonding—shown to occur experimentally37,38
and in QM calculations38,39—that takes advantage of the direc-
tionality of the lone pairs of the acceptor group. To model the sc
(i)→mc(i− 4) hydrogen bond accurately and measure their
strength in terms of electron density, we performed MD simula-
tions by means of the hybrid QM/MM methodology, which can in
addition account for a series of effects that are overlooked in
classical force fields such as lone pair directionality and electronic
polarization. Specifically, given our results (Fig. 5b, c), the side
chain carboxamide of the Gln residue at position i and the main
chain CO group of Leu at position i− 4 in peptide L4Q16 were
included in the QM subsystem, which was described at the DFT
level of theory (see Fig. 6a). We performed a simulation of 150 ps
at 300 K for L4Q16 started from a specific frame of the classical MD
trajectory where the bifurcate bond is formed (Fig. 6), and focused
our analysis on the interaction between Q1 and L1 (Fig. 5b).
Our analysis showed that the main chain to main chain
hydrogen bond between Q1 and L1, mc(Q1)→mc(L1) is stable,
that the sc(Q1)→mc(L1) bond can form reversibly, and that its
breakage is caused by deviations of χ3 from the value required for
the donor and acceptor to interact (+90 ± 30°, Figs. 4c, d and 6b,
c). To study how the sc(Q1)→mc(L1) bond affects the mc
(Q1)→mc(L1) interaction, we compared the effect of the former
on the distribution of donor to acceptor distances in the latter.
The unconventional side chain to main chain bond causes the
distribution to shift to longer distances, by 0.17 Å, thus weakening
the main chain to main chain bond. This observation thus
indicates that the main chain and side chain NHgroups of Q1
compete for the main chain CO group of L1 (Supplementary
Fig. 15). We then evaluated the strength of these interactions in
terms of electron density at the natural bond critical point of the
interaction, ρ(r)40,41. In the absence of the sc(Q1)→mc(L1)
bond, the mc(Q1)→mc(L1) bond has an average density of
0.012 a.u. and, in its presence, of 0.008 a.u. By contrast, even in
the presence of the mc(Q1)→mc(L1) bond, the value for the sc
(Q1)→mc(L1) interaction is instead 0.017a.u. on average, in
agreement with the notion that the Gln side chain is a better
donor than the main chain32. Importantly, the total density of the
bifurcate hydrogen bond is on average 0.025a.u. (Fig. 6c), thereby
indicating that the cumulative interaction between Q1 and L1 is
strong. These results show that the unconventional sc(i)→mc
(i− 4) hydrogen bonding interactions revealed in this work are
bifurcate with the conventional mc(i)→mc(i− 4) interactions
and enhance the stability of polyQ helices.
Discussion
Our results indicate that unconventional sc(i)→mc(i− 4)
hydrogen bonds donated by Gln side chains can stabilize the α-
helices formed by polyQ tracts. Furthermore, we have also found
that the strength of these bonds is determined by the residue type
of the acceptor: Leu residues are good acceptors while Ala resi-
dues are not. These results help explaining the residue-specific
structural properties of polyQ tracts reported in the recent
literature20,42,43. We found that the four Leu residues flanking the
polyQ tract of the AR at its N terminus are key for helicity20 and
can now attribute this to their high propensity to accept sc(i)→
mc(i− 4) hydrogen bonds. The tract of huntingtin also displays
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some helicity at low pH42,43, although lower than that observed in
the AR. Even though the ability of each particular type of residue
to act as a sc(i)→mc(i− 4) hydrogen bond acceptor remains to
be determined, the observation that only the first position in the
four-residue stretch—defining a turn of an α-helix—preceding
the polyQ tract in huntingtin is a Leu residue could explain the
lower secondary structure content of this tract.
The helical character of the polyQ tract is not homogeneously
distributed in either the AR or huntingtin and is instead found to
decrease gradually from the N terminus to the C terminus of the
tract20,42,43. Our results indicate that this can be explained by a
low propensity of Gln residues, relative to that of residues
flanking the tracts at their N terminus, to accept sc(i)→mc(i−
4) hydrogen bonds. Unless interrupted by residues with a high
propensity to accept such bonds, such as Leu, helicity will decay
towards the C terminus of the tract. In addition, our results
provide a mechanistic interpretation of the results obtained by
Kandel, Hendrickson and co-workers2 regarding the effect of
increasing the coiled coil character of polyQ tracts by interrupting
them with Leu residues. These authors found that the peptides
were fully helical and remained so after dissociation of the coiled
coil upon heating to temperatures as high as 348 K due, we
propose, to the presence of sc(i)→mc(i− 4) hydrogen bonds,
with Leu acting as acceptor.
We attribute the high propensity of Leu residues to accept sc
(i)→mc(i− 4) hydrogen bonds to the proximity of the hydrogen
bond to the Leu side chain. This can prevent water molecules
from donating a hydrogen to the carbonyl of that residue and,
due to high energetic cost associated with the presence of
unpaired hydrogen bonding partners36, greatly strengthen its
interaction with the Gln side chain at position i+ 4 despite the
entropic cost of constraining its conformation (Figs. 4 and 6).
Relatively dry environments where phenomena equivalent to this
can occur include the core of globular proteins44 and the interior
of cell membranes45, as well as amyloid fibrils, where hydrogen
bonding interactions involving Gln and Asn side chains parallel
to the fibril axis contribute to the stability of the quaternary
structure46. In addition, it has been shown that both exon 1 of
huntingtin47 and the transactivation domain of the AR48 form
condensates that define environments of low dielectric constant,
where electrostatic interactions may be strongly favored49. It will
be interesting to address whether this phenomenon plays a role in
the highly cooperative liquid–liquid phase separation process of
these and similar proteins, as has been proposed to be the case for
protein folding, where considering the context-dependent
strength of inter-residue interactions proved important for
reproducing the high cooperativity of protein folding in lattice
simulations50.
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PolyQ tracts are frequently found in transcriptional regulators,
particularly in transcription factors1. In several cases, the tran-
scriptional activity of these molecules has been found to be
dependent on the length of the polyQ tracts that they harbor; the
physical basis of this phenomenon has, however, not been firmly
established to date1,51. Our results provide a plausible rationale as
they suggest that variations in the length of polyQ tracts result in
changes in the secondary structure of the transactivation domain
of transcription factors. Indeed, such variations can affect the
strength of the protein–protein interactions52, particularly of
those regulating transcription53, which include interactions with
transcriptional co-regulators and with general transcription fac-
tors. Whether a certain change in tract length causes a decrease or
an increase in activity might depend on whether the polyQ tract
and its flanking regions are involved in interactions with tran-
scriptional co-activators or co-repressors and should therefore be
context-dependent, as found experimentally51,54.
A number of in vitro experiments have established that the
formation of fibrillar aggregates by proteins bearing polyQ tracts
can proceed via oligomers55, potentially liquid-like56, stabilized
by intermolecular interactions between flanking regions of polyQ
tracts and equivalent to those stabilizing coiled coils2,57,58. In
proteins bearing polyQ tracts such as huntingtin59,60 and AR20,21
extending the length of the tract increases its helicity and, as we
have now shown, that of the sequence immediately flanking them
at the N terminus. Remarkably, this also appears to be the case
when they are studied in the context provided by the domains
where they are found20,21 and, indeed, in that provided by full-
length protein60. It is therefore conceivable that this extension
will change the secondary structure and thus the strength of the
interactions that stabilize these oligomers52, and, potentially, the
rate at which they convert into fibrils. Our data thus suggest that
tract expansion can alter the structure and the stability of the
oligomers populated on the fibrillization pathway and conse-
quently modify the rate at which toxic fibrillar species build up14.
In summary, we have shown that side chain to main chain
hydrogen bonds donated by Gln side chains can substantially
increase the helical propensity of polyQ sequences. In addition,
we found that, for a given sequence context, tract expansion
increases helical propensity due to the accumulation of these
unconventional interactions. Such hydrogen bonds, that are due
to high propensity of the carboxamide group of the Gln side
chain to donate hydrogens, are so energetically favored that they
can offset the entropic cost of constraining the range of con-
formations available to the side chain. In addition, we have shown
that the strength of these interactions depends on the degree to
which the Gln side chains are exposed to water, implying that the
secondary structure of polyQ tracts may vary depending on
solution conditions, oligomerization state, and interactions with
other molecules. Our findings provide a plausible mechanistic
explanation for the link between polyQ tract length, AR tran-
scriptional activity and solubility, and for the range of AR polyQ
tract lengths found in the healthy male population. More gen-
erally, they suggest that changes in helicity may underlie the effect
of tract length changes on transcriptional activity and on aggre-
gation via helical oligomeric intermediates in polyQ diseases.
Methods
CD experiments. All synthetic peptides were obtained as lyophilized powders with
>95% purity from GenScript (Piscataway, NJ, USA) with free N and C termini.
They were dissolved in 6 M guanidine thiocyanate (Merck KGaA, Darmstadt,
Germany) and incubated overnight at 298 K to ensure that the resulting solutions
were monomeric. The denaturant was removed by size exclusion chromatography
in an Äkta Purifier system (GE Healthcare, Chicago, IL, USA) equipped with a
Superdex Peptide 10/300 GL column equilibrated in MilliQ water with 0.1% tri-
fluoroacetic acid. The fractions corresponding to the monomeric peptides were
collected, pooled, and centrifuged at 104,000 rpm for 3 h in an Optima TLX
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tabletop ultracentrifuge equipped with a TLA 120.1 rotor (Beckman Coulter,
Atlanta, GA, USA). Sodium phosphate buffer was added to a final concentration of
20 mM, and the samples were adjusted to pH 7.4 prior to quantification and
analysis by CD. The former was performed by reversed-phase chromatography in
an Agilent 1200 HPLC system (Agilent Technologies, Santa Clara, CA, USA)
equipped with a Phenomenex Jupiter 5 μm C18 300Å column (Torrance, CA,
USA) or, for the peptides with a Tyr residue, by measuring the absorbance at 280
nm by using 1490 cm−1 M−1 as value of the Tyr molar extinction coefficient. CD
spectra were acquired on 30 μM samples in a Jasco 815 UV spectro-
photopolarimeter at 277 K with a 1 mm optical path cuvette, and their deconvo-
lution to determine secondary structure propensities was performed with the
analysis programme CONTIN (reference set 7) hosted at DichroWeb61
(dichroweb.cryst.bbk.ac.uk). In Fig. 5d, to estimate the uncertainty in the helicity
values obtained in this deconvolution, which relies on an accurate quantification of
the peptide concentration, in addition to the value obtained without scaling the
experimental spectrum, we plot those obtained after scaling it by factors 0.9
and 1.1.
NMR experiments. Synthetic genes coding for peptides L4Q4 to L4Q20 (Fig. 1a)
fused to His6-SUMO and codon-optimized for expression in Escherichia coli
(Supplementary Table 1) were obtained cloned in a pDEST-17 expression vector
from GeneArt (Thermo Fisher Scientific, Waltham, MA, USA). The corresponding
constructs were expressed in Rosetta (DE3)pLysS E. coli-competent cells—Novagen
(Merck), in M9 medium containing 15NH4Cl and 13C-glucose as sole nitrogen and
carbon sources, obtained from Cambridge Isotope Laboratories, Inc. (Tewksbury,
MA, USA). After cell lysis in a 20 mM Tris-HCl buffer containing 100 mM NaCl
and 20 mM imidazole, the soluble fractions were purified by immobilized metal
affinity chromatography (IMAC) in an Äkta Purifier System (GE Healthcare,
Chicago, IL, USA) equipped with a HisTrap HP 5mL column. The eluted fractions
containing the His6-SUMO-tagged peptides were pooled and dialyzed against the
lysis buffer to remove imidazole before digesting them with SUMO protease (0.05
mg/mL). Cleaved peptides were further purified by a second IMAC step and
dialyzed against pure MilliQ water before lyophilization. The lyophilized recom-
binant 15N-13C-enriched peptides were treated in the same way as the synthetic
ones to prepare 100 μM samples for the NMR experiments, which were in all cases
carried out in a 600MHz Bruker Avance spectrometer equipped with a cryoprobe.
The samples contained 10 μM DSS (4,4-dimethyl-4-silapentane-1-sulfonic acid) for
chemical shift referencing. The backbone resonances of peptides L4Q4 to L4Q20
were assigned using three-dimensional (3D) triple resonance experiments (HNCO,
HN(CA)CO, HN(CO)CA, HN(CO)CACB) acquired with NUS at 278 K. The side
chain resonances were assigned with 3D H(CC)(CO)NH, (H)CC(CO)NH experi-
ments. NMR experimental data were processed using qMDD62 for non-uniform
sampled data and NMRPipe63 for all uniformly acquired experiments. The syn-
thetic peptides L4Q16 and L1-4A were prepared as detailed above to reach a final
concentration of 250 μM and characterized by two-dimensional homonuclear (total
correlation spectroscopy (TOCSY) and nuclear Overhauser effect spectroscopy
(NOESY)) and heteronuclear (1H,15N-HSQC, at natural 15N abundance) experi-
ments. The TOCSY and NOESY mixing times were 70 and 200 ms, respectively.
Molecular dynamics. Input coordinates were generated using MacPyMOL in fully
helical conformations. All simulations were performed in MD simulation software
ACEMD64 using the CHARMM22*65 force field, which was designed to have an
accurate helix-coil balance. Each system was explicitly solvated in the TIP3P water
model inside cubic boxes from 25 to 40 Å distance around the peptides, depending
on their length, and neutralized with Cl− and Na+ ions. Initial conformations were
minimized and equilibrated under NPT conditions at 1 atm and 300 K for 1 ns.
Production simulations were performed at 300 K in the NVT ensemble using a 4-fs
time-step for up to 5 µs.
Analysis and trajectory reweighting by maximum entropy. The secondary
structure of individual frames was analyzed with DSSP66, and the chemical shifts
were back-calculated with the predictor PPM67. The trajectories were reweighted to
match the experimental chemical shifts by means of a BME method30. The BME
approach contains a single, free parameter (θ) that determines the balance between
fitting the experimental data and not deviating too much from the prior infor-
mation encoded in the force field. We chose θ= 4 for the analysis shown in the
main text, as an analysis revealed that this value provides a good balance between
the two terms (Supplementary Fig. 9). The results for other values of θ are shown in
Supplementary Fig. 8.
QM/MM calculations. The starting structure was selected from the classical MD
simulations of L4Q16, preserving the previously defined box of water and ions. The
AMBER 16 program68 interfaced to the Terachem 1.9 program (www.petachem.
com, accessed June 1, 2017) was used for the QM/MM simulation. QM atoms were
described at the BLYP/6-31G* level, including a dispersion correction69. The
classical subsystem was described with the CHARMM22*65 force field by making
use of the Chamber keyword of Parmed program included in AMBERTOOLS 1668.
The link atoms procedure, as implemented in AMBER program, was used to
saturate the valence of the frontier atoms. Periodic boundary conditions were
employed with an electrostatic cutoff of 12 Å. A time-step of 1 fs was employed.
The structure was first minimized and then equilibrated for 10 ps in a QM/MM-
MD run. A production run was then performed with a total simulation time of
150 ps. The Natural Bond Critical Point analysis70,71 was performed with the NBO
6.0 program72.
Hydrogen bond criteria. To classify whether two atoms are hydrogen bonded, we
used angle and distance criteria. Specifically, we defined hydrogen bonds as those
where the distance between the donor and the acceptor was shorter than 3.4 Å (2.4
Å between H and heavy atom) and the donor hydrogen–acceptor angle was >120°.
Model structures. After reweighting, we calculated the residue-specific helicity for
all of the peptides using the algorithm DSSP66. For model structure selection,
residues that were in the helical conformation in more than 50% of the simulation
were defined as helical and the rest as random coil. From the simulation, the
structures that fit this definition were selected and colored on the basis of their
average helicity, shown in Fig. 3c. Color scale goes from dark blue (0% helicity) to
dark red (78% helicity).
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The chemical shifts of peptides L4Q4, L4Q8, L4Q12, L4Q16, and L4Q20 have been deposited
in the BMRB (www.bmrb.wisc.edu) with accession codes 27713, 27714, 27715, 27716,
and 27717. Other data are available from the corresponding authors upon reasonable
request.
Code availability
The code used to reweight the ensembles is available at https://github.com/KULL-Centre/
BME
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